The Hematology Track is ideal for fellows with a strong interest in an academic career in benign and/or malignant hematology. After completing the first year of single-board training in Hematology, fellows can either choose to:
- Enter directly into 2 years of mentored academic research training or
- Extend their clinical training by an additional 6 months to receive dual certification in Medical Oncology, followed by 18 months of research training
During the first year, Hematology Track fellows will rotate through the following clinical services:
Benign Hematology Inpatient Service
This unique inpatient hematology ward and consult experience run by the Division of Hematology provides fellows with intensive training to help them master inpatient management of benign hematologic diseases such as coagulation disorders, thrombotic thrombocytopenic purpura (TTP)/hemolytic uremic syndrome (HUS), hemophilia, bone marrow failure, paroxysmal nocturnal hemoglobinuria (PNH), and sickle cell disease.
This inpatient acute leukemia service exposes fellows to standard and trial chemotherapeutic regimens for the treatment of newly diagnosed or relapsed acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and aggressive myelodysplastic syndrome (MDS). In addition, fellows will learn the essentials of bone marrow biopsy and intrathecal chemotherapy techniques.
Myeloma, Transplant & Lymphoma (MTL) Service
This bone marrow transplant (BMT) ward provides fellows with training on a wide spectrum of BMT techniques such as autologous, allogeneic, matched-unrelated, haploidentical, and T cell depleted. Indications for BMT on this ward range from malignant diseases to genetic and autoimmune disorders.
This rotation through the Division of Hematologic Pathology is designed to enhance skills in diagnosing lymphomas, leukemias, and bone marrow failure disorders. Fellows will become proficient in interpreting bone marrow biopsies, peripheral blood smears, lymph node biopsies, special stains and flow cytometry.
This unique rotation through the Hematology & Coagulation Laboratory provides fellows with the skills to interpret hematology laboratory tests including complex hemostasis panels, platelet function studies, hemoglobinopathy evaluations, viscosity studies, peripheral blood smears and bone marrow aspirates from patients with adult and pediatric blood disorders. During this rotation, fellows will also rotate though hemophilia clinic and other hemostasis/thrombosis clinics.
This rotation through the Division of Transfusion Medicine exposes fellows to both theoretical concepts and practical experience in blood bank administration, donor procedures, donor testing, reference immunohematology, platelet serology, transfusion consultations, cytopheresis, bone marrow processing and therapeutic apheresis.
Sickle Cell Disease
This unique rotation designed to be an immersive experience in sickle cell disease care, including comprehensive outpatient care of sickle cell disease patients, acute pain management through the sickle cell infusion center, and newborn screening for sickle cell disease.
Outpatient Hematologic Malignancy Service (Heme OPD):
This unique inpatient/outpatient consult service provides fellows with the basics of diagnosis and chemotherapeutic management of patients with a wide variety of hematologic malignancies. Initial consults are seen with world-renowned experts; thereafter, fellows serve as the primary longitudinal oncologic provider in their weekly continuity clinic with continued oversight by the faculty attending.
Hematologic Malignancies Continuity Clinic
This weekly clinic during the first year provides fellows with autonomy and targeted training in the outpatient chemotherapeutic management of hematologic malignancies including chronic and aggressive lymphomas, myeloma, and MDS.
Adult Benign Hematology Continuity Clinic
This weekly clinic during the second year allows fellows to direct outpatient workup, management and consultation for patients with hematologic disorders such as thrombotic/bleeding diseases, myeloproliferative neoplasms, immune cytopenias, neutropenia syndromes, and anemias.